Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Cancer is now the leading cause of early death worldwide – yet research published in
The Lancet Oncology and also presented at the 2015 European Cancer Congress in Vienna, shows that more than 90 percent of the population in low-income countries lacks access to radiotherapy services to help treat it.
The data was compiled by a panel of international experts on the Lancet Oncology's Radiotherapy Commission to expand global access to radiotherapy, led by Dr. David Jaffray, Head of the International Secretariat of the Global Task Force on Radiotherapy for Cancer Control (GTFRCC).
Dr. Jaffray is the Head of Radiation Physics at Princess Margaret Cancer Centre, Director of TECHNA Research Institute and Executive Vice-President, Technology & Innovation at University Health Network.
Building capacity for radiotherapy
"There is a rapidly growing cancer burden worldwide and in many cases, radiotherapy is essential for effective treatment of the most common cancers seen in low-income and middle-income countries," says Dr. Jaffray.
"Even in high-income countries, radiotherapy is used in more than half of all cases of cancer to cure localized disease, palliate symptoms, and manage disease in incurable cancers."
"Yet, in planning and building treatment capacity for cancer, radiotherapy is frequently the last resource to be considered," he adds.
Radiotherapy treatment, also known as radiation therapy, is essential for the cure and palliation of most cancers including breast, lung, prostate, head and neck, and cervical cancers.
By 2035, more than 12 million people per year diagnosed with cancer would benefit from treatment
New estimates produced for the Commission find that in 2035, more than 12 million new cancer patients could benefit from radiotherapy treatment. Yet, worldwide access to radiotherapy is unacceptably low, with only 40 to 60 per cent of cancer patients having access to this vital treatment.
Experts on the Commission conclude that the lives saved and economic benefits of decreasing the burden of cancer care on health systems worldwide would far outweigh the cost of scaling up radiotherapy services.
The building of radiotherapy capacity will require a large initial investment – however, the report published on Sept. 26 states that the health and economic benefits will be realized in just 10 to 15 years.
"To justify the investment, we only need to look at the remarkable progress made in tackling the enormous challenges of HIV/AIDS and malaria," says Dr. Mary Gospodarowicz, Medical Director, Princess Margaret Cancer Centre and co-investigator on the GTFRCC, which was
launched at the Princess Margaret in 2014.
"This gives us the hope and confidence that the same success can be achieved with cancer control and radiotherapy."
The Commission analysis measures coverage of radiotherapy services worldwide and by country. It also includes new estimates for the future burden of cancer to 2035 and for the first time, calculates the costs and benefits of meeting the worldwide shortfall in resources and bridging the gap in access to effective treatment.
The work of the
Global Task Force on Radiotherapy for Cancer was coordinated by the Toronto Team supported by Tracey Lui from TECHNA and included Drs. Mike Milosevic, Brian O'Sullivan, Miller MacPherson and Danielle Rodin, radiation oncology resident and head of young leaders group
GlobalRT, who was highly involved in the investment framework working with Professor Rifat Atun from Harvard, lead author of the report.
Commission's call-to-action: Six key targets